Operating income decreased 106.1%
Operating income changed -106.1% from the comparable as-filed period.
-$29.5M→-$60.8M2 prior comparisons
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Operating income changed -106.1% from the comparable as-filed period.
Free-cash-flow proxy changed -65.5% from the comparable as-filed period.
Operating cash flow changed -65.4% from the comparable as-filed period.
Research & development changed +126.7% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.